The First International Symposium on IgG4-Related Systemic Disease

第一届IgG4相关系统性疾病国际研讨会

• 批准号: 8122944
• 负责人: John H Stone
• 金额: $ 2.25万
• 依托单位: MASSACHUSETTS GENERAL HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-05-01 至 2012-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8122944
• 关键词: Academic Medical Centers; Address; Adoption; Area; Biological Markers; Blood Vessels; Clinical; Clinical Research; Clinical Trials; Collaborations; Communities; Consensus; Data; Development; Diagnosis; Diagnostic; Disease; Fostering; Functional disorder; Gastroenterology; General Hospitals; Goals; Head and neck structure; Hepatobiliary; Hypersensitivity; IgG4; Image; Immune; Immunology; International; Knowledge; Lead; Massachusetts; Medicine; Monitor; Multi-Institutional Clinical Trial; Operative Surgical Procedures; Outcome Measure; Pathogenesis; Pathologic; Pathology; Patients; Radiology Specialty; Research; Research Personnel; Rheumatology; Sampling; Secure; Staging; Systemic disease; Testing; Time; autoimmune pancreatitis; body system; clinical care; data sharing; disease diagnosis; gastrointestinal; indexing; insight; instrument; medical specialties; meetings; novel; novel strategies; prototype; standard care; standard of care; symposium; theories; validation studies

DESCRIPTION (provided by applicant): We plan to organize and conduct the world's first international symposium on IgG4- related systemic disease (IgG4-RSD). We have secured commitments from the world's major researchers to participate in this Symposium. The expertise of our Organizing Committees spans the full spectrum of current knowledge about IgG4-RSD, and includes expertise from at least a dozen subspecialties within medicine, surgery, pathology, and radiology, among which are Rheumatology, Immunology, Allergy, Gastroenterology, Gastrointestinal Pathology, Vascular Pathology, Head & Neck Pathology, cross-sectional imaging (Radiology), and Hepatobiliary Surgery. We have developed an agenda that addresses the major questions confronting researchers and clinicians in the field today, from the many unknowns surrounding disease pathogenesis to the clinical spectrum of disease. The agenda will also cover diagnostic criteria, the development of disease activity indices, consensus discussions on standard approaches to therapy, and novel treatments. We anticipate several new directions emerging from the Symposium, including validation studies for outcome measures, more directed discussions about pathologic criteria for the disease across organ systems, plans for data and sample sharing, and the development of clinical trials. The proposed Symposium will have a galvanizing effect on the world's IgG4-RSD investigators at a time when the possibility of novel treatment approaches and new insights into pathophysiology exist.

描述（由申请人提供）：我们计划组织和举办世界上首次关于IGG4相关系统疾病（IGG4-RSD）的国际国际研讨会。我们已经从世界主要研究人员那里获得了参加此研讨会的承诺。 The expertise of our Organizing Committees spans the full spectrum of current knowledge about IgG4-RSD, and includes expertise from at least a dozen subspecialties within medicine, surgery, pathology, and radiology, among which are Rheumatology, Immunology, Allergy, Gastroenterology, Gastrointestinal Pathology, Vascular Pathology, Head & Neck Pathology, cross-sectional imaging (Radiology), and肝胆管手术。我们已经制定了一个议程，该议程解决了当今该领域的研究人员和临床医生面临的主要问题，从围绕疾病发病机理的许多未知数到疾病的临床范围。该议程还将涵盖诊断标准，疾病活动指数的发展，关于治疗标准方法的共识讨论以及新颖的治疗方法。我们预计研讨会会出现多个新方向，包括有关结果指标的验证研究，跨器官系统疾病的病理标准的更多定向讨论，数据和样品共享计划以及临床试验的发展。拟议的研讨会将对世界的IGG4-RSD研究者产生镀锌作用，此时存在新的治疗方法并对病理生理学的新见解。